 |
|
|
|
|
Welcome
to the
Vétoquinol UK site |
|
We
at Vétoquinol cordially invite
you to look around
our website, with
a click of your mouse you can now link your day-to-day
practice with the latest developments from Vétoquinol.
For nearly 80 years the Vétoquinol group has
been dedicated to animal health and the veterinary
surgeons that work in it. As a result of its own
research and in collaboration with partners, Vétoquinol
regularly provides new and innovative products to
the profession. Now the 10th largest veterinary company
in the world, we continue to seek solutions to the
problems in veterinary practice.
|
|
|
|
|
Do you Fancy Winning 1000 of Love2Shop vouchers?
07/02/2012 |
|
During March we are running a urinary incontinence awareness competition in conjunction with Propalin syrup. We are giving away free Urinary incontinence awareness packs which give you all the tools you need to create your notice board display, and a chance to win: 1st Place - 1000 worth of Love2Shop gift vouchers, 2nd Place - 500 worth of Love2Shop gift vouchers and 3rd Place 200 worth of Love2Shop gift vouchers.
All you need to do to enter is order your pack by calling 01280 814500, create your own unique notice board display, take a photo of it, then upload it onto the gallery at www.propalin.co.uk before 31st March 2012 for your chance to win.
The competition is open to all veterinary surgeons and veterinary nurses in registered UK veterinary practices. To enter ask your local Vetoquinol Territory Manager for a notice board competition pack or request one by ringing 01280 814500. |
|
Forcyl: Think Short-Acting for Long-Term Benefits
01/11/2011 |
|
November 2011 sees the launch of Forcyl, an innovative injectable anti-infective for the targeted therapeutic treatment of respiratory infections in cattle, from Vétoquinol UK Ltd.
Forcyl is a patented 16% marbofloxacin solution, registered as a single intramuscular injection, ensuring a high level of compliance.
Forcyl follows the SISAAB concept (single injection short acting antibiotic), with an optimised dosage to minimise the risk of development of antibiotic resistance. Shorter exposure time limits the opportunity for resistance to develop. The innovative formulation means a lower volume of administration (10 ml for 160 kg body weight) is required. Other benefits of Forcyl include excellent injection site tolerance and short withdrawal periods (meat: 5 days, milk: 48 hours). Think Short-Acting for Long-Term Benefits. |
|
Vetoquinol Launches Cimalgex
27/10/2011 |
|
Vetoquinol have launched Cimalgex, a new non-steroidal anti-inflammatory drug (NSAID) which contains Cimicoxib. Cimalgex is licensed for the treatment of pain and inflammation associated with osteoarthritis, and the management of peri-operative pain due to orthopaedic or soft tissue surgery, in dogs.
For further information on canine pain and Cimalgex please visit www.cimydog.co.uk |
|
|
|
|
|
|
|
|
